Barrett A, Eyre TA, Bhuva S, Aljurf M, Fakih RE, Ashshi MA, Alshaibani A. Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib - Case report.
EJHAEM 2024;
5:238-241. [PMID:
38406527 PMCID:
PMC10887248 DOI:
10.1002/jha2.830]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 10/30/2023] [Accepted: 11/07/2023] [Indexed: 02/27/2024]
Abstract
Central nervous system (CNS) involvement by mantle cell lymphoma (MCL) is rare and portends a poor prognosis. We describe the first patient to have a complete response with front-line treatment with single-agent acalabrutinib for MCL CNS.
Collapse